chr10-122082649-T-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_206862.4(TACC2):āc.149T>Cā(p.Ile50Thr) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000424 in 1,603,386 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_206862.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TACC2 | NM_206862.4 | c.149T>C | p.Ile50Thr | missense_variant, splice_region_variant | 4/23 | ENST00000369005.6 | NP_996744.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TACC2 | ENST00000369005.6 | c.149T>C | p.Ile50Thr | missense_variant, splice_region_variant | 4/23 | 1 | NM_206862.4 | ENSP00000358001 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152132Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000285 AC: 7AN: 245586Hom.: 0 AF XY: 0.0000226 AC XY: 3AN XY: 132712
GnomAD4 exome AF: 0.0000455 AC: 66AN: 1451254Hom.: 0 Cov.: 31 AF XY: 0.0000472 AC XY: 34AN XY: 720454
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152132Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74322
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 24, 2023 | The c.149T>C (p.I50T) alteration is located in exon 4 (coding exon 3) of the TACC2 gene. This alteration results from a T to C substitution at nucleotide position 149, causing the isoleucine (I) at amino acid position 50 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at